First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD -8.7% Market Closed
Updated: May 3, 2024

Valeo Pharma Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Valeo Pharma Inc
Operating Income Peer Comparison

Comparables:
BHC
TH
K
GUD
EDT
CPH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Valeo Pharma Inc
TSX:VPH
Operating Income
-CA$17.2m
CAGR 3-Years
-59%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Operating Income
$1.6B
CAGR 3-Years
7%
CAGR 5-Years
26%
CAGR 10-Years
6%
Theratechnologies Inc
TSX:TH
Operating Income
-$7.5m
CAGR 3-Years
27%
CAGR 5-Years
-30%
CAGR 10-Years
2%
K
Knight Therapeutics Inc
TSX:GUD
Operating Income
CA$6.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Operating Income
-CA$11.7m
CAGR 3-Years
-9%
CAGR 5-Years
-38%
CAGR 10-Years
0%
Cipher Pharmaceuticals Inc
TSX:CPH
Operating Income
$10m
CAGR 3-Years
-6%
CAGR 5-Years
14%
CAGR 10-Years
-5%

See Also

What is Valeo Pharma Inc's Operating Income?
Operating Income
-17.2m CAD

Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Operating Income amounts to -17.2m CAD.

What is Valeo Pharma Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-48%

Over the last year, the Operating Income growth was 10%. The average annual Operating Income growth rates for Valeo Pharma Inc have been -59% over the past three years , -48% over the past five years .